Little Journey offers a personalised platform that prepares and supports children and their families through medical journeys, combining evidence-based practices with clinician and young-people input. The app is used in over 100 hospitals across 11 countries, has localised content in 20 languages, and has supported thousands of young patients. The platform covers support for 12 procedures (including MRI, mental health and neurodevelopment assessment, and blood tests), reports a 25% adoption rate within the NHS, and a 97% family satisfaction rate. Little Journey partners with global pharmaceutical companies and CROs to improve paediatric clinical trial recruitment, adherence, and completion. Future plans include scaling globally with a focus on the US, enhancing scalable content, interoperability, and data-collection capabilities, and improving app accessibility for children with disabilities. The company aims to mature its systems and product security to support broader global adoption. Little Journey provides an app designed to help children reduce hospital anxiety through engaging, interactive, age-appropriate content. The app aims to psychologically prepare and support families throughout healthcare interactions. The company also offers a web portal for healthcare staff to configure app content, build virtual patient pathways, and edit key information in near real time. Little Journey intends to use the €2.8m funding to expand internationally and further develop the product. The round was led by Octopus Ventures. The company was founded by Dr Chris Evans and Sophie Copley and is based in London, UK. Little Journey builds a mobile app to help children prepare for surgery by providing virtual tours of hospitals, interactive animations explaining each stage, games, relaxation guides and resources for parents. The platform has been shown to reduce anxiety by 30% in high-risk patients such as those with autism or ADHD, cut same-day operation cancellations by 42%, and improve recovery times by 30%. It is currently used in over 50 hospitals worldwide and recently won a contract with a large clinical research organisation to support participants in an international paediatric trial. The Leeds-based company was launched by Dr Chris Evans, an anaesthetist, together with product designer Sophie Copley; Dr Evans serves as CEO. The new funding will be used to create 12 new jobs, further develop the technology (including more personalised solutions) and drive uptake in the UK and overseas. As part of the investment the company appointed Dr Nicolaus Henke as Chair.

Total raised

$17M

Funding rounds

5

Latest round

Series A

Latest activity

Nov 2024